A detailed history of Havens Advisors LLC transactions in Meridian Bioscience Inc stock. As of the latest transaction made, Havens Advisors LLC holds 26,800 shares of VIVO stock, worth $0. This represents 2.29% of its overall portfolio holdings.

Number of Shares
26,800
Previous 77,000 65.19%
Holding current value
$0
Previous $2.43 Million 63.34%
% of portfolio
2.29%
Previous 3.63%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 25, 2023

SELL
$31.15 - $33.39 $1.56 Million - $1.68 Million
-50,200 Reduced 65.19%
26,800 $0
Q3 2022

Oct 12, 2022

BUY
$30.9 - $33.55 $2.38 Million - $2.58 Million
77,000 New
77,000 $2.43 Million

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Havens Advisors LLC Portfolio

Follow Havens Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Havens Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Havens Advisors LLC with notifications on news.